Tianjin Chase Sun Pharmaceutical Co., Ltd. announced that at its EGM held on September 26, 2014, shareholders elected Mr. Li Shu and Mr. Shang Hongcai as independent directors of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.61 CNY | -0.55% | -3.73% | -14.86% |
29/03 | Tianjin Chase Sun Pharmaceutical Co.,Ltd Proposes Final Dividend for 2023 | CI |
01/03 | Tianjin Chase Sun Pharmaceutical's 2023 Profit Slides 15% on Weak Revenue | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.86% | 1.51B | |
+37.65% | 6.11B | |
-19.68% | 4.33B | |
+4.49% | 3.22B | |
-15.69% | 2.96B | |
-5.64% | 2.42B | |
+44.89% | 1.92B | |
-12.71% | 1.61B | |
-4.27% | 1.57B | |
+42.40% | 1.46B |
- Stock Market
- Equities
- 300026 Stock
- News Tianjin Chase Sun Pharmaceutical Co.,Ltd
- Tianjin Chase Sun Pharmaceutical Co., Ltd Announces Election of Directors